Sledovat
Marta Relvas-Santos
Marta Relvas-Santos
Portuguese Oncology Institute of Porto Research Centre & LAQV-REQUIMTE, Faculty of Sciences of University of Porto
E-mailová adresa ověřena na: ipoporto.min-saude.pt
Název
Citace
Citace
Rok
Protein glycosylation and tumor microenvironment alterations driving cancer hallmarks
A Peixoto, M Relvas-Santos, R Azevedo, LL Santos, JA Ferreira
Frontiers in oncology 9, 380, 2019
3012019
CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications
R Azevedo, C Gaiteiro, A Peixoto, M Relvas-Santos, L Lima, LL Santos, ...
Clinical proteomics 15, 1-5, 2018
642018
Glycoengineered nanoparticles enhance the delivery of 5-fluoroucil and paclitaxel to gastric cancer cells of high metastatic potential
E Fernandes, D Ferreira, A Peixoto, R Freitas, M Relvas-Santos, ...
International Journal of Pharmaceutics 570, 118646, 2019
422019
Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer
R Azevedo, J Soares, C Gaiteiro, A Peixoto, L Lima, D Ferreira, ...
Talanta 184, 347-355, 2018
362018
Nucleolin-Sle A glycoforms as E-selectin ligands and potentially targetable biomarkers at the cell surface of gastric cancer cells
E Fernandes, R Freitas, D Ferreira, J Soares, R Azevedo, C Gaiteiro, ...
Cancers 12 (4), 861, 2020
312020
Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer
A Peixoto, D Ferreira, R Azevedo, R Freitas, E Fernandes, ...
Journal of Experimental & Clinical Cancer Research 40 (1), 191, 2021
302021
Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion
C Gaiteiro, J Soares, M Relvas-Santos, A Peixoto, D Ferreira, P Paulo, ...
Theranostics 12 (7), 3150, 2022
272022
Target score—a proteomics data selection tool applied to esophageal cancer identifies GLUT1-sialyl tn glycoforms as biomarkers of cancer aggressiveness
S Cotton, D Ferreira, J Soares, A Peixoto, M Relvas-Santos, R Azevedo, ...
International Journal of Molecular Sciences 22 (4), 1664, 2021
182021
Glycoproteogenomics: setting the course for next-generation cancer neoantigen discovery for cancer vaccines
JA Ferreira, M Relvas-Santos, A Peixoto, A MN Silva, L Lara Santos
Genomics, Proteomics & Bioinformatics 19 (1), 25-43, 2021
182021
Protein glycosylation and tumor microenvironment alterations driving Cancer hallmarks. Front Oncol. 2019; 9: 380
A Peixoto, M Relvas-Santos, R Azevedo, LL Santos, JA Ferreira
Epub 2019/06/04. https://doi. org/10.3389/fonc. 2019.00380 PMID: 31157165, 2019
112019
Single-pot enzymatic synthesis of cancer-associated MUC16 O-glycopeptide libraries and multivalent protein glycoconjugates: a step towards cancer glycovaccines
R Freitas, M Relvas-Santos, R Azevedo, J Soares, E Fernandes, ...
New Journal of Chemistry 45 (20), 9197-9211, 2021
92021
Metabolomics, transcriptomics and functional glycomics reveals bladder cancer cells plasticity and enhanced aggressiveness facing hypoxia and glucose deprivation
A Peixoto, R Freitas, D Ferreira, M Relvas-Santos, P Paulo, M Cardoso, ...
BioRxiv, 2021.02. 14.431133, 2021
62021
Protein glycosylation and tumor microenvironment alterations driving cancer hallmarks. Front Oncol
A Peixoto, M Relvas-Santos, R Azevedo, LL Santos, JA andFerreira
62019
A multivalent CD44 glycoconjugate vaccine candidate for cancer immunotherapy
R Freitas, A Miranda, D Ferreira, M Relvas-Santos, F Castro, E Ferreira, ...
Journal of Controlled Release 367, 540-556, 2024
52024
Multilevel plasticity and altered glycosylation drive aggressiveness in hypoxic and glucose-deprived bladder cancer cells
A Peixoto, D Ferreira, A Miranda, M Relvas-Santos, R Freitas, TS Veth, ...
iScience 28 (2), 2025
32025
Targeted and Self-Adjuvated Nanoglycovaccine Candidate for Cancer Immunotherapy
R Freitas, E Ferreira, A Miranda, D Ferreira, M Relvas-Santos, F Castro, ...
ACS nano 18 (14), 10088-10103, 2024
32024
Glycoproteogenomics characterizes the CD44 splicing code driving bladder cancer invasion
C Gaiteiro, J Soares, M Relvas-Santos, A Peixoto, D Ferreira, A Brandão, ...
bioRxiv, 2021.09. 04.458979, 2021
22021
Stool glycoproteomics signatures of pre-cancerous lesions and colorectal cancer
J Soares, M Eiras, D Ferreira, DAR Santos, M Relvas-Santos, B Santos, ...
International Journal of Molecular Sciences 25 (7), 3722, 2024
12024
Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer
E Ferreira, D Ferreira, M Relvas-Santos, R Freitas, J Soares, R Azevedo, ...
International Journal of Molecular Sciences 25 (6), 3462, 2024
12024
GlycoAvatars: Bead-Coated Membrane Models for Studying the Cancer-Immune Cells Interactome
A Miranda, M Relvas-Santos, C Lourenco, E Ferreira, DM Cunha, ...
bioRxiv, 2025.01. 15.633146, 2025
2025
Systém momentálně nemůže danou operaci provést. Zkuste to znovu později.
Články 1–20